chromium(3+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
chromium(3+) — decreases C-reactive protein concentration
Evidence strength: very limited.Findingreplicated ×3“In addition, taking chromium led to a significant reduction in serum high-sensitivity C-reactive protein (hs-CRP) (β - 0.49 mg/L; 95% CI, - 0.91, - 0.06; P = 0.02) and plasma malondialdehyde (MDA) levels (β - 0.22 μmol/L; 95% CI, - 0.35, - 0.10; P = 0.001); also, a significant rise in total antioxidant capacity (TAC) (β 84.54 mmol/L; 95% CI, 31.05, 138.02; P = 0.002) was observed in comparison with placebo.”
Quoted verbatim from The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.. - Study
- RCT
- Dose
- 200 μg chromium daily for 12 weeks
- Population
- 64 patients with type 2 diabetes and coronary heart disease
The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.2020PMID:3124368510.1007/s12011-019-01783-7Permalink
To cite this finding: https://catalystproject.ai/e/01M5MEEA5V9P1JKHMTETX3A2ZF